%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2020-10-09T20:20:53+05:30Arbortext Advanced Print Publisher2020-10-12T01:23:02-07:002020-10-12T01:23:02-07:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalJournal of Enzyme Inhibition and Medicinal Chemistry© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.3511840-18531840185310.1080/14756366.2020.1825408https://doi.org/10.1080/14756366.2020.1825408application/pdf10.1080/14756366.2020.1825408en-USDesign of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluationTaylor & FrancisJournal of Enzyme Inhibition and Medicinal Chemistry, 2020. doi: 10.1080/14756366.2020.1825408Elie JonathanFeizbakhsh OmidDesban NathalieJosselin BéatriceBaratte BlandineBescond AmandineDuez JulienFant XavierBach StéphaneMarie DominiquePlace MatthieuBen Salah SamiChartier AgnesBerteina-Raboin SabineChaikuad ApiratKnapp StefanCarles FabriceBonnet PascalBuron FrédéricRoutier SylvainRuchaud SandrineImidazopyridazineHaspin kinaseco-crystallisation and dockingcellular effects3D spheroidsVoR2020-10-12truewww.tandfonline.com10.1080/14756366.2020.1825408www.tandfonline.comtrue2020-10-1210.1080/14756366.2020.1825408
endstream
endobj
4 0 obj
<>stream
xZ[%9
~_Ql tio#'`a;q3iԪ:UN˓;,o5cOkwhQb6>O{MhfwW >j:5!ֿ֚ZppwGn|uwx-|{_C;|p..ܿWx}M)zsߨ]}Fl7l
loPbΔZ1&^DB~ #Z}z
^ҟG}"F1Jd,b
|6WwA/-N7